Takeaway
Measuring standard motor outcomes can detect change over time in patients with FKRP mutations, and age and genotype should be considered in design of future clinical trials.
Why this matters
Understanding the natural history of motor function as it relates to FKRP mutations will aid in the design of future clinical trials.